Exosomes From Cancer‐Associated Fibroblasts Suppress Ferroptosis and CD8 + T Cell Effector Function in Gastric Cancer via miR ‐4435/ NDUFA10 Axis
The FASEB Journal · 2026
DOI: 10.1096/fj.202602170r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Yingying Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Exosomes, MicroRNAs, Cancer-Associated Fibroblasts. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Hebei Natural Science Foundation, Hengrui Hebei Innovative Development Medical Cooperation Program, Government-funded Program for Clinical Medicine Talents.
Abstract (Originalsprache)
Cancer‐associated fibroblasts (CAFs) are pivotal stromal component in tumor microenvironment (TME) and participate in regulating tumor development and progression via exosomes (exos) mediated intercommunication. However, the intricate mechanism underlying the exosomal miRNAs from CAFs in gastric cancer (GC) tumorigenesis remains ambiguous. Herein, we found that miR‐4435 was highly expressed in both CAFs‐ derived exos and GC tissues and was associated with TNM stage as well as tumor size in GC patients. Additionally, inhibition of miR‐4435 remarkably restricted GC proliferation, migration, and invasion in vitro and in vivo; whereas facilitating ferroptosis in GC cells. Moreover, miR‐4435 could bind with the downstream target NDUFA10 mRNA and was shown to silence NDUFA10 expression. Importantly, exosomal miR‐4435 derived from CAFs could suppress CD8 + T cells effector function, contributing to immune resistance, while knockdown of miR‐4435 in CAFs‐exo could foster CD8 + T cells effector function and enhanced the sensitivity of anti‐PD‐1 therapy in GC. Collectively, exosomal miR‐4435 derived from CAFs suppress ferroptosis and CD8 + T cell effector function in GC via mediating NDUFA10. Our results highlight exos‐transfered miR‐4435 as a potential therapeutic target in GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
- General Surgery Department, Hebei Children's Hospital, Shijiazhuang, China.
- Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Bibo Tan
Förderung
- Hebei Natural Science Foundation
- Hengrui Hebei Innovative Development Medical Cooperation Program
- Government-funded Program for Clinical Medicine Talents
- Medical Science Research Project of Hebei
- Natural Science Foundation of Hebei Province
Zitieren
APA
Wang, Y., Liu, W., Yang, Z., Geng, J., Jia, N., Wang, X., Song, B., Li, Y., Yang, L., & Tan, B. (2026). Exosomes From Cancer‐Associated Fibroblasts Suppress Ferroptosis and CD8 + T Cell Effector Function in Gastric Cancer via miR ‐4435/ NDUFA10 Axis. The FASEB Journal. https://doi.org/10.1096/fj.202602170r
Vancouver
Wang Y, Liu W, Yang Z, Geng J, Jia N, Wang X, et al. Exosomes From Cancer‐Associated Fibroblasts Suppress Ferroptosis and CD8 + T Cell Effector Function in Gastric Cancer via miR ‐4435/ NDUFA10 Axis. The FASEB Journal. 2026. doi:10.1096/fj.202602170r
BibTeX
@article{Wang2026,
author = {Wang, Yingying and Liu, Wenbo and Yang, Zhiran and Geng, Jianlei and Jia, Nan and Wang, Xiaoxiao and Song, Buyun and Li, Yong and Yang, Liwei and Tan, Bibo},
title = {Exosomes From Cancer‐Associated Fibroblasts Suppress Ferroptosis and CD8 + T Cell Effector Function in Gastric Cancer via miR ‐4435/ NDUFA10 Axis},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202602170r}
}
EUVIMED